Implant Sciences Cp (IMSC) 0.6999 $IMSC
Implant Sciences' (IMSC) CEO Bill McGann on Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu May 14, 6:31PM CDT
Implant Sciences Reports Third Quarter Fiscal 2015 Financial Results
PR Newswire - Thu May 14, 3:05PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced financial results for the three and nine months ended March 31, 2015.
Implant Sciences Ships Additional $500,000 of Explosives Trace Detectors Worldwide
PR Newswire - Wed May 13, 11:29AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the Company has continued its sales momentum, announcing the shipment of over $500,000 explosives trace detectors worldwide. These units, which include both the desktop QS-B220 explosives and drugs trace detector as well as the handheld QS-H150 explosives trace detector, will be used by customers for applications such as air cargo and critical infrastructure protection.
Implant Sciences Continues to Innovate - Granted Three More U.S. Patents for Trace Detection
PR Newswire - Mon May 11, 10:25AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the company has been granted three new patents by the U.S. Patent and Trademark Office.
Implant Sciences to Announce Third Quarter Fiscal 2015 Financial Results
PR Newswire - Fri May 08, 3:01PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the Company will host a webcast and conference call on Thursday, May 14, 2015 at 4:15 p.m. to discuss the financial results for the quarter ended March 31, 2015.
Major French Airport Selects Implant Sciences' ETDs
PR Newswire - Wed Apr 29, 11:30AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the Company has received an order for 25 QS-B220 explosives trace detection systems from a major airport in France. The systems, which will be used to fulfill the recent European security regulations requirement for screening passengers and checked bags, are expected to be delivered in the Company's fourth fiscal quarter, ending June 30, 2015.
Implant Sciences Announces another Significant ECAC Win
PR Newswire - Tue Apr 21, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today reported that the Company has received an order for 75 QS-B220 explosives trace detection systems in the Netherlands. The systems are expected to be delivered in the Company's fourth fiscal quarter and will be used for screening passengers and baggage in an airport environment.
Implant Sciences Receives Order for 66 Explosives Trace Detection Systems in Norway
PR Newswire - Thu Apr 16, 9:52AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today reported that the Company has received an order for 66 QS-B220 explosives trace detection systems in Norway. The systems, many of which have already been shipped, are scheduled to be deployed for passenger and baggage screening in an airport environment.
Implant Sciences Announces Restructuring
PR Newswire - Wed Apr 15, 11:47AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced restructuring actions to better align costs with current and future geographic revenue sources and to improve efficiencies. The actions, which include increasing outreach and sales and marketing efforts, reducing expenses and other actions to align with our markets, are expected to result in a pre-tax charge of approximately $200,000 which will be recorded in the quarter ended March 31, 2015. The charge is primarily related to expenses incurred to relocate the San Diego, CA advanced technology office and costs related to closing our Shanghai office and converting our sales model in Southeast Asia from direct selling to in-country distribution. The Company expects the restructuring will result in annual pre-tax reductions of approximately $2 million in annual operating expenses, the benefits of which will begin in the fourth quarter of fiscal 2015, with the full savings expected to be achieved in fiscal 2016.
Implant Sciences' Executive Vice President Interviewed by Bloomberg TV about Boston Marathon Bombing Verdict
PR Newswire - Thu Apr 09, 11:45AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that Former Assistant Secretary for the Department of Homeland Security and Implant Sciences Corporation Executive Vice President, Robert Liscouski, was interviewed on Bloomberg TV about the Boston Marathon Bombing verdict. Mr. Liscouski discussed the vulnerabilities and potential for similar attacks in the future.
Implant Sciences Ships $500,000 Follow-On Order of QS-B220s to Kuehne + Nagel for U.S. Air Cargo Screening
PR Newswire - Wed Apr 08, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today it has shipped a follow-on order for approximately $500,000 of its QS-B220 explosives trace detectors to Kuehne + Nagel, one of the worlds' leading logistics companies. The QS-B220s will be deployed across a total of ten facilities for air cargo screening in the U.S. This order follows the customer's initial order in 2014.
Major International Airline in Latin America Adopts QS-B220
PR Newswire - Thu Mar 26, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today reported the shipment of approximately $500,000 in explosives trace detection systems in Latin America, most of which were sold to a major international airline in Latin America.
Implant Sciences Ships $750,000 of Explosives Trace Detector Systems to Asia
PR Newswire - Mon Mar 23, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today reported the shipment of more than $750,000 in explosives trace detection systems to various customers in Asia. The shipments include a mixture of QS-H150 and QS-B220 systems, and will be deployed in military, aviation security, and critical infrastructure protection applications.
Implant Sciences Extends Credit Agreements
PR Newswire - Thu Mar 19, 6:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced the extension of its March 2014 secured credit agreements with DMRJ Group, LLC and the group of investors represented by BAM Administrative Services, LLC.
Implant Sciences to Exhibit at Passenger Terminal Expo 2015 in Paris, France on March 10 - 12, 2015
PR Newswire - Tue Mar 10, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today the Company will exhibit its QS-B220 desktop explosives trace detector at booth #3090 on March 10 - 12, 2015 at the Passenger Terminal Expo 2015 in Paris, France.
Implant Sciences to Move Forward with Explosives Trace Detection Bid
PR Newswire - Mon Mar 09, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today that it has received notification that the bid protest filed with the Government Accountability Office (GAO) regarding the Company's recent 1,170 unit ETD award under Solicitation HSTS04-14-R-CT2050 has been denied. The stop work order has been lifted and the TSA order, initially issued on November 10, 2014, will ship according to TSA's delivery schedule.
Implant Sciences' (IMSC) CEO William McGann on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Feb 17, 8:22PM CST
Implant Sciences Reports Second Quarter Fiscal 2015 Financial Results
PR Newswire - Tue Feb 17, 3:05PM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, today announced financial results for the three and six months ended December 31, 2014.
Implant Sciences To Announce Second Quarter Fiscal 2015 Financial Results
PR Newswire - Fri Feb 13, 3:15PM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, will host a webcast and conference call on Tuesday, February 17, 2015 at 4:15 PM ET to discuss the financial results for the quarter ended December 31, 2014.
Implant Sciences Appoints Robert Liscouski as Executive Vice President
PR Newswire - Mon Feb 09, 6:00AM CST
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today the appointment of Robert Liscouski into the newly created position of Executive Vice President. Mr. Liscouski will manage and drive the company's business strategy, business development and branding efforts. Mr. Liscouski will report to Dr. William McGann, Chief Executive Officer. Mr. Liscouski will continue to serve on the Company's Board of Directors.
Implant Sciences' (IMSC) CEO Bill McGann on Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu May 14, 6:31PM CDT
Implant Sciences Reports Third Quarter Fiscal 2015 Financial Results
PR Newswire - Thu May 14, 3:05PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced financial results for the three and nine months ended March 31, 2015.
Implant Sciences Ships Additional $500,000 of Explosives Trace Detectors Worldwide
PR Newswire - Wed May 13, 11:29AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the Company has continued its sales momentum, announcing the shipment of over $500,000 explosives trace detectors worldwide. These units, which include both the desktop QS-B220 explosives and drugs trace detector as well as the handheld QS-H150 explosives trace detector, will be used by customers for applications such as air cargo and critical infrastructure protection.
Implant Sciences Continues to Innovate - Granted Three More U.S. Patents for Trace Detection
PR Newswire - Mon May 11, 10:25AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the company has been granted three new patents by the U.S. Patent and Trademark Office.
Implant Sciences to Announce Third Quarter Fiscal 2015 Financial Results
PR Newswire - Fri May 08, 3:01PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the Company will host a webcast and conference call on Thursday, May 14, 2015 at 4:15 p.m. to discuss the financial results for the quarter ended March 31, 2015.
Major French Airport Selects Implant Sciences' ETDs
PR Newswire - Wed Apr 29, 11:30AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that the Company has received an order for 25 QS-B220 explosives trace detection systems from a major airport in France. The systems, which will be used to fulfill the recent European security regulations requirement for screening passengers and checked bags, are expected to be delivered in the Company's fourth fiscal quarter, ending June 30, 2015.
Implant Sciences Announces another Significant ECAC Win
PR Newswire - Tue Apr 21, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today reported that the Company has received an order for 75 QS-B220 explosives trace detection systems in the Netherlands. The systems are expected to be delivered in the Company's fourth fiscal quarter and will be used for screening passengers and baggage in an airport environment.
Implant Sciences Receives Order for 66 Explosives Trace Detection Systems in Norway
PR Newswire - Thu Apr 16, 9:52AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today reported that the Company has received an order for 66 QS-B220 explosives trace detection systems in Norway. The systems, many of which have already been shipped, are scheduled to be deployed for passenger and baggage screening in an airport environment.
Implant Sciences Announces Restructuring
PR Newswire - Wed Apr 15, 11:47AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced restructuring actions to better align costs with current and future geographic revenue sources and to improve efficiencies. The actions, which include increasing outreach and sales and marketing efforts, reducing expenses and other actions to align with our markets, are expected to result in a pre-tax charge of approximately $200,000 which will be recorded in the quarter ended March 31, 2015. The charge is primarily related to expenses incurred to relocate the San Diego, CA advanced technology office and costs related to closing our Shanghai office and converting our sales model in Southeast Asia from direct selling to in-country distribution. The Company expects the restructuring will result in annual pre-tax reductions of approximately $2 million in annual operating expenses, the benefits of which will begin in the fourth quarter of fiscal 2015, with the full savings expected to be achieved in fiscal 2016.
Implant Sciences' Executive Vice President Interviewed by Bloomberg TV about Boston Marathon Bombing Verdict
PR Newswire - Thu Apr 09, 11:45AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that Former Assistant Secretary for the Department of Homeland Security and Implant Sciences Corporation Executive Vice President, Robert Liscouski, was interviewed on Bloomberg TV about the Boston Marathon Bombing verdict. Mr. Liscouski discussed the vulnerabilities and potential for similar attacks in the future.
Implant Sciences Ships $500,000 Follow-On Order of QS-B220s to Kuehne + Nagel for U.S. Air Cargo Screening
PR Newswire - Wed Apr 08, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today it has shipped a follow-on order for approximately $500,000 of its QS-B220 explosives trace detectors to Kuehne + Nagel, one of the worlds' leading logistics companies. The QS-B220s will be deployed across a total of ten facilities for air cargo screening in the U.S. This order follows the customer's initial order in 2014.
Major International Airline in Latin America Adopts QS-B220
PR Newswire - Thu Mar 26, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today reported the shipment of approximately $500,000 in explosives trace detection systems in Latin America, most of which were sold to a major international airline in Latin America.
Implant Sciences Ships $750,000 of Explosives Trace Detector Systems to Asia
PR Newswire - Mon Mar 23, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today reported the shipment of more than $750,000 in explosives trace detection systems to various customers in Asia. The shipments include a mixture of QS-H150 and QS-B220 systems, and will be deployed in military, aviation security, and critical infrastructure protection applications.
Implant Sciences Extends Credit Agreements
PR Newswire - Thu Mar 19, 6:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced the extension of its March 2014 secured credit agreements with DMRJ Group, LLC and the group of investors represented by BAM Administrative Services, LLC.
Implant Sciences to Exhibit at Passenger Terminal Expo 2015 in Paris, France on March 10 - 12, 2015
PR Newswire - Tue Mar 10, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today the Company will exhibit its QS-B220 desktop explosives trace detector at booth #3090 on March 10 - 12, 2015 at the Passenger Terminal Expo 2015 in Paris, France.
Implant Sciences to Move Forward with Explosives Trace Detection Bid
PR Newswire - Mon Mar 09, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today that it has received notification that the bid protest filed with the Government Accountability Office (GAO) regarding the Company's recent 1,170 unit ETD award under Solicitation HSTS04-14-R-CT2050 has been denied. The stop work order has been lifted and the TSA order, initially issued on November 10, 2014, will ship according to TSA's delivery schedule.
Implant Sciences' (IMSC) CEO William McGann on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Feb 17, 8:22PM CST
Implant Sciences Reports Second Quarter Fiscal 2015 Financial Results
PR Newswire - Tue Feb 17, 3:05PM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, today announced financial results for the three and six months ended December 31, 2014.
Implant Sciences To Announce Second Quarter Fiscal 2015 Financial Results
PR Newswire - Fri Feb 13, 3:15PM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, will host a webcast and conference call on Tuesday, February 17, 2015 at 4:15 PM ET to discuss the financial results for the quarter ended December 31, 2014.
Implant Sciences Appoints Robert Liscouski as Executive Vice President
PR Newswire - Mon Feb 09, 6:00AM CST
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today the appointment of Robert Liscouski into the newly created position of Executive Vice President. Mr. Liscouski will manage and drive the company's business strategy, business development and branding efforts. Mr. Liscouski will report to Dr. William McGann, Chief Executive Officer. Mr. Liscouski will continue to serve on the Company's Board of Directors.
